2
4
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Systemic lupus erythematosus rash on the face
Systemic lupus erythematosus rash on the face
Blood clots
Blood clots

Lupus anticoagulants
Definition:
Lupus anticoagulants are antibodies against phospholipids (a group of substances in cell membranes) which inhibit blood clotting in a test tube, but may be associated with a higher risk of clotting in people who have them in their blood.

Causes, incidence, and risk factors:

Lupus anticoagulants are found in people with auto-immune diseases, such as systemic lupus erythematosis (SLE) and also in those taking certain medications, such as phenothiazines.

Some people with these antibodies have no clear, predisposing factor. In some cases, the condition is associated with an increased risk of blood clots and it may be the cause of recurrent miscarriages.

Symptoms:
  • Blood clots in veins
  • Blood clots in arteries
  • Recurrent miscarriages

The condition can also occur with no symptoms.
Signs and tests:
  • Elevated PTT
  • Abnormal tissue thromboplastin inhibition test
  • Prolonged dilute Russell viper venom time
Treatment:
No treatment is required in the absence of symptoms. If clots occur, patients should be anticoagulated with heparin followed by warfarin. Higher than usual doses of warfarin may be required. Steroids are sometimes effective in decreasing the level of antibody, but it is not clear whether this decreases clotting risk.
Expectations (prognosis):
The outcome is usually good with appropriate therapy. Some patients have difficult to control clots, with recurrent symptoms.
Complications:
  • Stroke
  • Heart attack
  • Blood clot in lungs (pulmonary embolism)
Calling your health care provider:
Call your health care provider if you notice symptoms of clot, such as swelling or redness in the leg; shortness of breath; or pain, numbness and pallor in an extremity.
Prevention:
Awareness of risk factors may allow early diagnosis. Prevention may not be possible.
Review Date: 10/17/2001
Reviewed By: Rebecca Elstrom, M.D., Division of Hematology-Oncology, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com